rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Rocket One Inc.

RKTO · Nasdaq

Health CareBiotechnologyNot moving yetAIDefense-TechSpace Economy

RKTO stood above a rising 150-day average in 2 of the last 52 weekly readings, and has been out of that trend for the last 50 weeks. It is 39.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 50
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
20 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 2 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders20+1 on the quarter
New · exited6 · 4
Reported value$1.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026683,291$683K+553,600+426.9%
JANE STREET GROUP, LLCnew · filed 14 Aug 2026219,316$219K+219,316
UBS Group AGadded · filed 13 Aug 2026211,304$211K+53,327+33.8%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026195,982$196K-18,262−8.5%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202684,318$84K00.0%
STATE STREET CORPunchanged · filed 7 Aug 202663,939$64K00.0%
LPL Financial LLCnew · filed 7 Aug 202641,029$41K+41,029
NORTHERN TRUST CORPreduced · filed 13 Aug 202638,724$39K-3,330−7.9%
SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 202625,966$26K+25,966
Lido Advisors, LLCreduced · filed 7 Aug 202619,500$20K-19,500−50.0%
31 Mar 2023 – 30 Jun 2026
91521Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Christopher Michael Camarra Company insiderDirector · last 26 May 20260 · 0
David Sarnoff Company insiderDirector · last 26 May 20260 · 0
Jeff Pavell Company insiderDirector · last 26 May 20260 · 0
Robb Knie Company insiderCEO and President · last 26 May 20263 · 0
Wayne Linsley Company insiderDirector · last 26 May 20260 · 0
Graig Springer Company insiderDirector · last 14 Jan 20250 · 0
Stefanie Johns Company insiderChief Scientific Officer · last 16 Mar 20220 · 0
Vadim Mats Company insiderDirector · last 29 Jan 20210 · 0
Kenneth L. Rice, Jr. Company insiderDirector · last 21 Jul 20200 · 0
Aikido Pharma Inc. Company insider10% owner · last 26 May 20202 · 1
Anthony Hayes Company insiderOther · last 26 May 20200 · 2
David S. Briones Company insiderChief Financial Officer · last 6 Mar 20190 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 26 Mar 20264.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$6.2M

Analyst forecasts

No analyst forecasts yet.